Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer.

Forbes C, Fayter D, de Kock S, Quek RG.

Cancer Manag Res. 2019 Mar 22;11:2321-2337. doi: 10.2147/CMAR.S189627. eCollection 2019. Review.

2.

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Grimm SE, Fayter D, Ramaekers BLT, Petersohn S, Riemsma R, Armstrong N, Pouwels X, Witlox W, Noake C, Worthy G, Kleijnen J, Joore MA.

Pharmacoeconomics. 2019 Oct;37(10):1195-1207. doi: 10.1007/s40273-019-00792-7. Review.

3.

Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma : An Evidence Review Group Evaluation of the NICE Single Technology Appraisal.

Thielen FW, Büyükkaramikli NC, Riemsma R, Fayter D, Armstrong N, Wei CY, Huertas Carrera V, Misso K, Worthy G, Kleijnen J, Corro Ramos I.

Pharmacoeconomics. 2019 Aug;37(8):975-984. doi: 10.1007/s40273-018-0740-4. Review.

4.

Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Ramaekers BLT, Riemsma R, Grimm S, Fayter D, Deshpande S, Armstrong N, Witlox W, Pouwels X, Duffy S, Worthy G, Kleijnen J, Joore MA.

Pharmacoeconomics. 2019 Jul;37(7):887-894. doi: 10.1007/s40273-018-0738-y. Review.

5.

Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Büyükkaramikli NC, de Groot S, Riemsma R, Fayter D, Armstrong N, Portegijs P, Duffy S, Kleijnen J, Al MJ.

Pharmacoeconomics. 2019 Feb;37(2):141-153. doi: 10.1007/s40273-018-0708-4. Review.

6.

Trifluridine-Tipiracil for Previously Treated Metastatic Colorectal Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Ramaekers BLT, Wolff R, van Giessen A, Pouwels X, Fayter D, Lang S, Armstrong N, Worthy G, Duffy S, Kleijnen J, Joore MA.

Pharmacoeconomics. 2018 Mar;36(3):285-288. doi: 10.1007/s40273-017-0591-4. Review.

7.

Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.

Büyükkaramikli NC, de Groot S, Fayter D, Wolff R, Armstrong N, Stirk L, Worthy G, Albuquerque de Almeida F, Kleijnen J, Al MJ.

Pharmacoeconomics. 2018 Feb;36(2):145-159. doi: 10.1007/s40273-017-0581-6. Review.

8.

Systematic review of the evidence on orthotic devices for the management of knee instability related to neuromuscular and central nervous system disorders.

McDaid C, Fayter D, Booth A, O'Connor J, Rodriguez-Lopez R, McCaughan D, Bowers R, Iglesias CP, Lalor S, O'Connor RJ, Phillips M, Ramdharry G.

BMJ Open. 2017 Sep 5;7(9):e015927. doi: 10.1136/bmjopen-2017-015927. Review.

9.

Orthotic management of instability of the knee related to neuromuscular and central nervous system disorders: systematic review, qualitative study, survey and costing analysis.

O'Connor J, McCaughan D, McDaid C, Booth A, Fayter D, Rodriguez-Lopez R, Bowers R, Dyson L, Iglesias CP, Lalor S, O'Connor RJ, Phillips M, Ramdharry G.

Health Technol Assess. 2016 Jul;20(55):1-262. doi: 10.3310/hta20550. Review.

10.

An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review.

Norman G, Fayter D, Lewis-Light K, Chisholm J, McHugh K, Levine D, Jenney M, Mandeville H, Gatz S, Phillips B.

BMJ Open. 2015 Jan 8;5(1):e006030. doi: 10.1136/bmjopen-2014-006030. Review.

11.

Mind the gap: extent of use of diffusion-weighted MRI in children with rhabdomyosarcoma.

Norman G, Fayter D, Lewis-Light K, McHugh K, Levine D, Phillips B.

Pediatr Radiol. 2015 Apr;45(5):778-81. doi: 10.1007/s00247-014-3120-z. Epub 2014 Sep 11. No abstract available.

PMID:
25208650
12.

Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: network meta-analysis.

Corbett MS, Rice SJ, Madurasinghe V, Slack R, Fayter DA, Harden M, Sutton AJ, Macpherson H, Woolacott NF.

Osteoarthritis Cartilage. 2013 Sep;21(9):1290-8. doi: 10.1016/j.joca.2013.05.007. Review.

13.

Interventions for alcohol and drug problems in outpatient settings: a systematic review.

Watson JM, Fayter D, Mdege N, Stirk L, Sowden AJ, Godfrey C.

Drug Alcohol Rev. 2013 Jul;32(4):356-67. doi: 10.1111/dar.12037. Epub 2013 Mar 11. Review.

PMID:
23490212
14.

Interventions for reducing alcohol consumption among general hospital inpatient heavy alcohol users: a systematic review.

Mdege ND, Fayter D, Watson JM, Stirk L, Sowden A, Godfrey C.

Drug Alcohol Depend. 2013 Jul 1;131(1-2):1-22. doi: 10.1016/j.drugalcdep.2013.01.023. Epub 2013 Mar 6. Review.

PMID:
23474201
15.

Growth monitoring for short stature: update of a systematic review and economic model.

Craig D, Fayter D, Stirk L, Crott R.

Health Technol Assess. 2011 Feb;15(11):iii-iv, 1-64. doi: 10.3310/hta15110. Review.

16.
17.

Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model.

Chambers D, Epstein D, Walker S, Fayter D, Paton F, Wright K, Michaels J, Thomas S, Sculpher M, Woolacott N.

Health Technol Assess. 2009 Oct;13(48):1-189, 215-318, iii. doi: 10.3310/hta13480. Review.

18.

Use of non-randomised evidence alongside randomised trials in a systematic review of endovascular aneurysm repair: strengths and limitations.

Chambers D, Fayter D, Paton F, Woolacott N.

Eur J Vasc Endovasc Surg. 2010 Jan;39(1):26-34. doi: 10.1016/j.ejvs.2009.09.010. Epub 2009 Oct 15. Review.

19.

Population tobacco control interventions and their effects on social inequalities in smoking: systematic review.

Thomas S, Fayter D, Misso K, Ogilvie D, Petticrew M, Sowden A, Whitehead M, Worthy G.

Tob Control. 2008 Aug;17(4):230-7. doi: 10.1136/tc.2007.023911. Epub 2008 Apr 21. Review.

20.

The harvest plot: a method for synthesising evidence about the differential effects of interventions.

Ogilvie D, Fayter D, Petticrew M, Sowden A, Thomas S, Whitehead M, Worthy G.

BMC Med Res Methodol. 2008 Feb 25;8:8. doi: 10.1186/1471-2288-8-8. Review.

21.

A systematic review highlights threats to validity in studies of barriers to cancer trial participation.

Fayter D, McDaid C, Eastwood A.

J Clin Epidemiol. 2007 Oct;60(10):990-1001. Epub 2007 Jul 16. Review.

PMID:
17884592
22.

A systematic review of the routine monitoring of growth in children of primary school age to identify growth-related conditions.

Fayter D, Nixon J, Hartley S, Rithalia A, Butler G, Rudolf M, Glasziou P, Bland M, Stirk L, Westwood M.

Health Technol Assess. 2007 Jun;11(22):iii, xi-xii, 1-163. Review.

23.

Effectiveness and cost-effectiveness of height-screening programmes during the primary school years: a systematic review.

Fayter D, Nixon J, Hartley S, Rithalia A, Butler G, Rudolf M, Glasziou P, Bland M, Stirk L, Westwood M.

Arch Dis Child. 2008 Apr;93(4):278-84. Epub 2007 May 2. Review.

PMID:
17475693
24.

Childhood obesity: should primary school children be routinely screened? A systematic review and discussion of the evidence.

Westwood M, Fayter D, Hartley S, Rithalia A, Butler G, Glasziou P, Bland M, Nixon J, Stirk L, Rudolf M.

Arch Dis Child. 2007 May;92(5):416-22. Review.

25.

Increasing participation of cancer patients in randomised controlled trials: a systematic review.

Mc Daid C, Hodges Z, Fayter D, Stirk L, Eastwood A.

Trials. 2006 May 17;7:16.

Supplemental Content

Loading ...
Support Center